Anti-KAT3A / CBP抗体[CBP5I001] (ab50702)

发表研究结果有使用 ab50702?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab50702 被引用在 1 文献中.

  • Benedikt A  et al. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Leukemia 25:135-44 (2011). WB ; Human . PubMed: 21030982

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"